European Medicines' Agency launches new PRIME (PRIority MEdicines) scheme
European Medicines Agency chief defends against 'perceived delays' of vaccine authorizations
Benefits of the ipowder® extraction process applied to Melissa officinalis L.: improvement of antioxidant activity and in vitro gastro-intestinal rele ... - Food & Function (RSC Publishing) DOI:10.1039/C9FO01144G
PDF) The Medical use of Lemon Balm (Melissa officinalis) and Valerian (Valeriana officinalis) as Natural Sedatives: Insight into their Interactions with GABA Transmission
3 Key Takeaways from the EMA Clinical Trial Guidance Update | Healthcare Packaging
Europe's FDA Warns Against Vaccine Boosters, Expresses Concerns Over Immune Response - Invesbrain
melissa
The effect of Melissa officinalis L. extract on learning and memory: Involvement of hippocampal expression of nitric oxide synthase and brain-derived neurotrophic factor in diabetic rats - ScienceDirect
EMA revises fixed combination product guideline | Packaging World
melissa
EMA probes jab menstrual disorders reports
Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19 | Business Wire
FDA, EMA leaders address barriers, 'big projects,' and Brexit
Pharmacognosy & Herbal Medicine : Melissa
melissa
What is the role of the European Medicines Agency (EMA)? | AGE Platform
Pharmacognosy & Herbal Medicine : Melissa
Community herbal monograph on Melissa officinalis .14 May 2013 . EMA/HMPC/196745/2012 . Committee - [PDF Document]
Blood clots after Johnson & Johnson COVID vaccine under investigation